ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,031, issued on May 12, was assigned to Northwestern University (Evanston, Ill.).

"Inhibitors of ubiquitin specific peptidase 22 (USP22) and uses thereof for treating diseases and disorders" was invented by Deyu Fang (Evanston, Ill.), Amy Tang (Evanston, Ill.), Beixue Gao (Evanston, Ill.), Elena Montauti (Evanston, Ill.), Ming Yan (Evanston, Ill.) and Huiping Liu (Evanston, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating diseases or disorders associated with the expression of Ubiquitin Specific Peptidase 22 (USP22). The disclosed methods may be utilized to treat diseases or disorders associated with cell prolifera...